| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/15/2006 | US7091034 Appartus for use in accurate analysis and detection of preferential particles in sample |
| 08/15/2006 | US7091033 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression |
| 08/15/2006 | US7091026 Synthetic peptide for use in the treatment of cancer, inflammation and infections |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7091019 The use of these proteins enables the transformation of a hop by gene manipulations as well as enables the in vitro synthesis of the secondary metabolites of a hop. |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7091005 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 08/15/2006 | US7090997 Diagnostic agent and test method for colon cancer using tannase as index |
| 08/15/2006 | US7090996 measurement at one location of several metabolic parameters in biocompartments exposed to a culture medium; electrical potential is applied to form OH and H ions; taking a first and second pH measurement and calculating a difference between measurements |
| 08/15/2006 | US7090995 Biosenor for use in diagnosis of iron defects |
| 08/15/2006 | US7090994 Methods of screening for introduction of DNA into a target cell |
| 08/15/2006 | US7090991 System for detection of a functional interaction between a compound and a cellular signal transduction component |
| 08/15/2006 | US7090990 NP95: methods of assaying for cell cycle modulators |
| 08/15/2006 | US7090987 Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia |
| 08/15/2006 | US7090983 Methods for detecting early cancer |
| 08/15/2006 | US7090982 Mimetic polypeptide for treatment and prevention of nervous system disorders |
| 08/15/2006 | US7090981 Chicken anaemia viruses of low pathogenicity |
| 08/15/2006 | US7090980 Method of detecting acid-fast bacteria using ribosomal RNA as target |
| 08/15/2006 | US7090979 making very long, double-stranded synthetic poly-nucleotides by sequentially hybridizing short oligonucleotides to each other; enzymatic ligation of the oligonucleotides provides a contiguous piece of PCR-ready DNA of predetermined sequence. |
| 08/15/2006 | US7090978 Obtaining tissue or sample DNA or RNA from a potential tumor cell; Amplification by polymerase chain reaction; Southern hybridization or RNase A mismatch cleavage; useful in diagnosis and prognosis of cancer |
| 08/15/2006 | US7090977 Detection of nucleic acid hybridization; obtain sample, incubate with intercalating agent, detect signal, presence of signal indicates nucleotide sequence hybridization |
| 08/15/2006 | US7090976 Retroviral vector comprising green fluorescent reporter protein for use as diagnostic tool in genetic engineering |
| 08/15/2006 | US7090975 Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection |
| 08/15/2006 | US7090973 codes for polypeptides used for detection, prevention and prophylaxis of bacterial infections |
| 08/15/2006 | US7090972 hybridization assay using an oligonucleotide probe complementary to hybridize to a region of rRNA selected to be unique to a non-viral organism by comparing one or more variable region rRNA sequences with rRNA sequences of the organism to be detected; can distinguish between target and non-target species |
| 08/15/2006 | US7090971 identifying a compound capable of modulating trans-glutaminase (TG) kinase activity by determining if it activates or inhibits TG2 kinase activity as indicated by a TG2 mediated phosphorylation of the TG2 kinase |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | US7090840 Lactobacillus paracasei subsp. paracasei strain antibacterial against Helicobacter pylori and Escherichia coli 0157:h7 |
| 08/15/2006 | US7090808 Contacting under controlled sterilization conditions with flowing antimicrobial gas containing hydrogen peroxide vapor; for medical equipment |
| 08/15/2006 | US7090805 Kits for use in monitoring taste response |
| 08/15/2006 | US7090804 Amplification of nucleic acids with electronic detection |
| 08/15/2006 | US7090764 Applying large amplitude potential stimulus waveform to sample generates nonlinear current signal, via galvanostat/ potentiostat circuits |
| 08/15/2006 | US7090759 Apparatus and method for light-controlled electrokinetic assembly of particles near surfaces |
| 08/15/2006 | US7090756 Controller for redox system |
| 08/15/2006 | CA2222525C Electrochemical cell |
| 08/15/2006 | CA2182906C Highly specific surfaces for biological reactions, method of preparation and utilization |
| 08/11/2006 | WO2007126402A2 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 08/11/2006 | CA2596448A1 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 08/11/2006 | CA2496985A1 Method for the identification of a risk for a thrombogenic disorder by determining the tafi -ile347 polymorphism |
| 08/10/2006 | WO2006084272A2 Methods of predicting chemotherapy responsiveness in breast cancer patients |
| 08/10/2006 | WO2006084242A2 Tissue sensor and uses thereof |
| 08/10/2006 | WO2006084155A1 Hpv e6, e7 mrna assay and methods of use thereof |
| 08/10/2006 | WO2006084067A2 Dark quenchers, probes and other conjugates incorporating the same, their use |
| 08/10/2006 | WO2006084051A2 Use of id4 for diagnosis and treatment of cancer |
| 08/10/2006 | WO2006084018A2 Methods for determining responsiveness to cancer therapy |
| 08/10/2006 | WO2006083986A2 Biomarkers for tissue status |
| 08/10/2006 | WO2006083962A1 Selected compaction agents and methods and compositions for biotechnical separations |
| 08/10/2006 | WO2006083925A2 Highly orthogonal universal sequences for use in nucleic acid assays |
| 08/10/2006 | WO2006083854A2 Genetic basis of alzheimer's disease and diagnosis and treatment thereof |
| 08/10/2006 | WO2006083851A2 Method for detecting adverse reaction susceptibility to an hmg coa reductase inhibitor |
| 08/10/2006 | WO2006083657A2 Genetic markers associated with benign prostatic hyperplasia |
| 08/10/2006 | WO2006083516A2 Modified cyanovirin-n polypeptide |
| 08/10/2006 | WO2006083330A1 A method for the manipulation, storage, modeling, visualization and quantification of datasets |
| 08/10/2006 | WO2006083285A2 Radiation protection material using granulated vulcanized rubber, metal and binder |
| 08/10/2006 | WO2006083264A2 Octapole ion trap mass spectrometers and related methods |
| 08/10/2006 | WO2006083040A1 Method of detecting nucleic acid by using nucleic acid microarray |
| 08/10/2006 | WO2006083016A1 Substrates for use in detection of phosphorylation-dephosphorylation reaction and detection method using the same |
| 08/10/2006 | WO2006082916A1 Method of determining gene relating to favorable beef taste and texture |
| 08/10/2006 | WO2006082866A1 METHOD FOR DETECTING p53 DYSFUNCTION, METHOD FOR MOLECULAR DIAGNOSIS OF CANCER AND METHOD FOR EVALUATING COMPOUND EFFECTIVE IN TREATING CANCER |
| 08/10/2006 | WO2006082851A1 Mucin relating to epiglycanin |
| 08/10/2006 | WO2006082826A1 METHOD OF IDENTIFYING PURKINJE CELL TARGETING Corl2 GENE |
| 08/10/2006 | WO2006082685A1 Method for detecting single nucleotide polymorphism |
| 08/10/2006 | WO2006082570A1 Pharmacogenomics of blood pressure lowering agents |
| 08/10/2006 | WO2006082496A2 Method for determining hiv-1 viral load |
| 08/10/2006 | WO2006082414A1 Detection and diagnosis of cancer |
| 08/10/2006 | WO2006082402A2 Biochemical reagents and their uses |
| 08/10/2006 | WO2006082390A1 Materials and methods for diagnosis and treatment of chronic fatigue syndrome |
| 08/10/2006 | WO2006082385A1 Screening method |
| 08/10/2006 | WO2006082250A1 Screening method for competitive hiv rt inhibitors |
| 08/10/2006 | WO2006082249A1 Screening method for hiv rt inhibitors |
| 08/10/2006 | WO2006082237A1 Transcription regulating nucleotide sequence from solanaceae triose-phosphate translocator genes and their use in plant expression cassettes |
| 08/10/2006 | WO2006082059A1 Esterases for monitoring protein biosynthesis in vitro |
| 08/10/2006 | WO2006081831A1 Method of generating translationally active linear dna molecules and use thereof in array formats |
| 08/10/2006 | WO2006081718A1 Kit and method for the detection of anti-hepatitis c virus (hcv) antibodies |
| 08/10/2006 | WO2006081691A1 Apparatus and methods for concentrating and separating particles such as molecules |
| 08/10/2006 | WO2006081623A1 Double-stranded oligonucleotides and uses therefor |
| 08/10/2006 | WO2006068997A3 Nucleic acid analysis |
| 08/10/2006 | WO2006065350A3 Microbial detection and quantification |
| 08/10/2006 | WO2006062701A3 Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene |
| 08/10/2006 | WO2006045009A3 Triplex probe compositions and methods for polynucleotide detection |
| 08/10/2006 | WO2006044918A3 Compounds useful as substrates for enzymes that reverse nucleotidylylated peptide and protein modifications and methods for production and uses thereof |
| 08/10/2006 | WO2006044857A3 Vaccines against japanese encephalitis virus and west nile virus |
| 08/10/2006 | WO2006042811A3 A sensor film for transcutaneous insertion and a method for making the sensor film |
| 08/10/2006 | WO2006042005A3 Global gene expression profiling of circulating tumor cells |
| 08/10/2006 | WO2006034456A3 Compositions and methods for detecting and treating tumors |
| 08/10/2006 | WO2006031955A3 Method for treatment with bucindolol based on genetic targeting |
| 08/10/2006 | WO2006028634A3 Site specific pegylation of broadly-neutralizing antibodies against hepatitis c virus and their use in the treatment of chronic hcv infections |
| 08/10/2006 | WO2006027147A3 Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr) |
| 08/10/2006 | WO2006027099A3 Enzyme conjugates with a programmable specificity, which react in a highly specific manner with dna |
| 08/10/2006 | WO2006019429A3 Methods of identifying and using agents that increase inhibition of or resistance to hcv infection |
| 08/10/2006 | WO2005121376A3 Hiv variants showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant variant |
| 08/10/2006 | WO2005118880A3 Novel dna synthesis technology with 3’-beaded oligo dna and dna polymerase |
| 08/10/2006 | WO2005113791A3 Methods of identifying modulators of bacterial type iii protein secretion system |
| 08/10/2006 | WO2005110493A3 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress |
| 08/10/2006 | WO2005086770A3 Methods for genetic analysis |
| 08/10/2006 | WO2005084254A3 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription |
| 08/10/2006 | WO2005084190A3 Methods and compostions for targeted cleavage and recombination |
| 08/10/2006 | WO2005078124A3 Diagnostic marker for cancer |
| 08/10/2006 | WO2005077048A3 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells |